Targeted Therapeutics
OBJECTIVES
This course aims to allow you to :
-
Understand of the current therapeutic landscape of cancer therapy
-
Learn about the history of targeted therapeutics, and their classification
-
Understand how targeted therapeutics differ in their adverse event profile and reporting
-
Appreciate specific regulatory differences in the US FDA regarding targeted therapeutics
-
Understand the future directions of targeted therapies
-
Understand the current therapeutic landscape of cancer therapy
targeted therapeutics, adverse event, cancer, FDA
LEARNING OUTCOMES
At the end of the course, you will be able to :
|
|
180 minutes |
|
Online based learning |
|
English language |
|
Certificate of Achievement |
|
300 € / $320 |
|
REGISTER NOW
|
|
AUTHORS
|
Nasop Experts Group
ISoP's North American chapter
|
|
Dr. Pinak Joshi
Durg Safety Physician
Technical Resources International
|
This short course has been added to your Study List:
Targeted Therapeutics
Please note that this short course is currently in update.
It will be available within 15 working days.
This short course has been added to your Study List:
Targeted Therapeutics
COMPANIES OFFER
Short courses can be included in a training package for your team!
NEED TO TALK TO US?
+33 5 47 30 42 69
Monday-Friday / 9.00am-6.00pm CET
LOG IN OR SIGN UP TO "MY Eu2P"
